Establishment of the permanent certification program for health information technology. Final rule

This final rule establishes a permanent certification program for the purpose of certifying health information technology (HIT). This final rule is issued pursuant to the authority granted to the National Coordinator for Health Information Technology (the National Coordinator) by section 3001(c)(5) of the Public Health Service Act (PHSA), as added by the Health Information Technology for Economic and Clinical Health (HITECH) Act. The permanent certification program will eventually replace the temporary certification program that was previously established by a final rule. The National Coordinator will use the permanent certification program to authorize organizations to certify electronic health record (EHR) technology, such as Complete EHRs and/or EHR Modules. The permanent certification program could also be expanded to include the certification of other types of HIT.     

日本医师会医师赔偿责任保险制度介评

始建于1973年的日本医师会医师赔偿责任保险制度,经过近40年的发展,已成为日本医疗事故纠纷解决体系中的不可或缺的机制。该制度的实施不仅为医师供给了价格低廉的保险产品,还为医疗事故纠纷的解决提供便捷渠道。尽管这一制度还不尽完善,但这并不妨碍我们从中汲取经验和启示。     

网络信息时代电子病历的隐私保护研究

与传统纸质病历相比,电子病历信息的存储和共享的范围将进一步扩大,但同时也为隐私信息的暴露提供捷径。本文通过分析我国电子病历隐私保护现状及存在的问题,并对比发展较好的其他国家电子病历隐私保护历程,提出我国进一步完善电子病历隐私保护的建议。     

NGO在公共卫生服务中的角色分析

公共卫生服务是公共服务的内容之一。虽然公共卫生服务主要是政府的职责,但也是可以通过多种组织形态来提供的。本文分析了国家级NGO参与公共卫生项目的数量、比例和领域,提出了公共卫生服务中NGO的补充角色及其具体体现,包括在人力资源、资金、特殊领域和内容、特殊地区和人群以及服务模式探索等方面的补充作用,并从筹资和服务两个方面总结了NGO参与的方式。基于此,作者提出NGO和政府在公共卫生领域良性互动的模式。     

Blood vessels recovered with organs and intended for use in organ transplantation. Direct final rule

The Health Resources and Services Administration (HRSA) and the Food and Drug Administration (FDA) are amending their regulations to consider as part of an organ those blood vessels recovered with the organ that are intended for use in organ transplantation (HRSA regulation); and to exclude such blood vessels from the definition of human cells, tissues, and cellular and tissue-based products (HCT/Ps) (FDA regulation). We (HRSA and FDA) are taking this action to provide that blood vessels recovered with organs and intended for use in organ transplantation are governed by the regulations pertaining to organs. The regulation of other recovered blood vessels remains unchanged. We believe that this change will eliminate the unnecessary burden resulting from an organ procurement organization's efforts to comply with both FDA and HRSA rules with respect to blood vessels (FDA jurisdiction) and organs (HRSA jurisdiction). We are issuing these amendments directly as a final rule because they are noncontroversial, and there is little likelihood that we will receive any significant adverse comments. Elsewhere in this issue of the Federal Register, we are publishing a companion proposed rule under our usual procedures for notice and comment in the event that we receive any significant adverse comments on the direct final rule. If we receive any significant adverse comments that warrant terminating the direct final rule, we will consider such comments on the proposed rule in developing the final rule.     

Standards Improvement Project-Phase II. Final rule

The Occupational Safety and Health Administration (OSHA) through this final rule is continuing to remove and revise provisions of its standards that are outdated, duplicative, unnecessary, or inconsistent, or can be clarified or simplified by being written in plain language. The Agency completed Phase I of the Standards Improvement Project in June 1998. In this Phase II of the Standards Improvement Project, OSHA is again revising or removing a number of health provisions in its standards for general industry, shipyard employment, and construction. The Agency believes that the changes streamline and make more consistent the regulatory requirements in OSHA health and safety standards. In some cases, OSHA has made substantive revisions to requirements because they are outdated, duplicative, unnecessary, or inconsistent with more recently promulgated health standards. The Agency believes these revisions will reduce regulatory requirements for employers without reducing employee protection.